Lexapro for children: drug without significant benefits and increase in suicide gets FDA approval

In May, the FDA expanded the approval of drug giant AbbVie’s SSRI escitalopram (Lexapro) to include children ages seven and older who suffer from anxiety. The basis for the approval was a clinical trial conducted by AbbVie employees, with an article written by AbbVie’s ghostwriting company. Researchers randomly assigned 275 children aged 7 to 17 … Read more